Loading...
Creating long lasting visual impressions
Flow injection analysis-tandem MS (FIA-MS/MS) is the most commonly used primary screening method for the 33 metabolic disorders recommended by RUSP. In this technical note, authors verified the detection of 15 amino acids, 13 acylcarnitines, succinylacetone, and argininosuccinic acid in DBS cards ...
Read moreThe study was conducted as a part of nationwide program NATRIJOD aimed to evaluate sodium and iodine status in Lithuania (the country with 2 784 279 inhabitants in 2021). The prevalence of nTSH above 5 mU/l varied between 1.21 % (in 2013) and 5.43 % (in 2004). Since 2011 overall prevalence of nTS...
Read moreThe availability of reliable methods in terms of their analytical and diagnostic characteristics is a key requirement to guarantee an efficient neonatal detection of any screenable disorder. Moreover, automation feasibility, high throughput and low costs are additional but very important features ...
Read moreThe availability of reliable methods in terms of their analytical and diagnostic characteristics is a key requirement to guarantee an efficient neonatal detection of any screenable disorder. Moreover, automation feasibility, high throughput and low costs are additional but very important features th...
Read moreWe Want To Take An Active Role In India, So We’re Approaching State Governments…” Says Dr. P. Siva Kumar, CEO, Trivitron Healthcare – India In an interview with The Health Orange, Dr. P. Siva Kumar, CEO of Trivitron Healthcare Pvt. Ltd. gives us his valuable insights into Newborn Screenin...
Read more“We Want To Take An Active Role In India, So We’re Approaching State Governments…” Says Dr. P. Siva Kumar, CEO, Trivitron Healthcare – India In an interview with The Health Orange, Dr. P. Siva Kumar, CEO of Trivitron Healthcare Pvt. Ltd. gives us his valuable insights into Newborn Scree...
Read moreGlucose 6 phosphate dehydrogenase (G6PD) deficiency remains the most prevalent enzyme dificiency in the world. It is estimated that nearly 330 million people may be affected by G6PD deficiency worldwide with a global prevalence of 4.9%. The overall incedence of G6PD deficiency in Malaysia were 5.3% ...
Read more